Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2026-05-21 18:05:02 ET · period of report 2026-05-20 · accession 0001628280-26-037455 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 18:05 | 2026-05-20 | BMRN | Hubbard Cristin | EVP, Chief Commercial Off | F - Tax | $50.20 | -2,318 | 42.5K | -5% | -$116.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-20 | F | D | 2,318 | $50.20 | 42,472 | D | — | — |